Celanese Corporation - CE STOCK NEWS

Celanese Corporation (NYSE: CE) has completed a registered offering of $400 million in 1.400% Senior Notes due 2026. With a net borrowing rate of 1.421%, the proceeds will be used to repay existing debt under its revolving credit facility.

All $400 million outstanding was previously used to pay off 5.875% senior notes at maturity. CFO Scott Richardson highlighted that this transaction will extend the debt maturity profile and lower interest expenses, backed by a strengthened credit rating and outlook.

Celanese Corporation (NYSE: CE) reported strong second quarter results with GAAP diluted earnings per share of $4.81 and record adjusted earnings per share of $5.02. The company achieved net sales of $2.2 billion, driven by an 18% increase in pricing and a 4% volume rise. Consolidated operating profit reached $567 million, with adjusted EBIT of $691 million. The acquisition of Santoprene™ is anticipated to enhance future earnings. Shareholder returns included $326 million in buybacks and dividends.

Celanese Corporation (NYSE: CE) announced the expansion of its Florence, Kentucky R&D center with a new Pharmaceutical Drug Delivery Feasibility Lab. This expansion aims to enhance development for long-acting controlled release drug delivery, showcasing Celanese's commitment to its Pharmaceutical segment. The lab will provide services such as material characterization and prototyping capabilities, facilitating quicker project advancements for pharmaceutical companies. With over 40 years in the medical market, Celanese aims to innovate drug delivery solutions and improve patient health outcomes.

Celanese Corporation (NYSE:CE) has approved a new $1.0 billion share repurchase authorization, representing approximately 6 percent of the company’s outstanding shares. In the first half of 2021, Celanese utilized $500 million to buy back shares from a previous $1.5 billion authorization. As of June 30, 2021, $560 million remained under that authorization. The addition of this new buyback program supports ongoing shareholder value enhancement.

Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.68 per share, payable on August 9, 2021. Stockholders of record as of July 26, 2021 will receive the dividend. Celanese is a leading global chemical company with approximately 7,700 employees and reported $5.7 billion in net sales for 2020. The company focuses on differentiated chemistry solutions across various industries and aims to create shareholder value while positively impacting communities through The Celanese Foundation.

Celanese Corporation (NYSE: CE) will host a conference call on July 23, 2021, at 10:00 a.m. Eastern Time to discuss its second quarter 2021 results. The earnings release will be available after market close on July 22. Investors can access the webcast at Celanese Investors. A replay of the call will be accessible from July 23 until August 6, 2021. Celanese is a global leader in specialty materials, employing approximately 7,700 people, with 2020 net sales of $5.7 billion.

Celanese Corporation (NYSE: CE) has signed a definitive agreement to acquire the Santoprene™ TPV elastomers business from Exxon Mobil Corporation for $1.15 billion. This acquisition includes the Santoprene™, Dytron™, and Geolast™ brands, key production facilities, customer contracts, and a comprehensive intellectual property portfolio. Celanese expects the transaction to be accretive to its 2022 adjusted earnings per share and free cash flow. The acquisition aims to enhance Celanese's elastomers portfolio and drive shareholder value, focusing on growth in markets like mobility and sustainability.

Celanese Corporation (NYSE: CE) announced the acquisition of specific polyacetal (POM) production technology from Grupa Azoty S.A., which is discontinuing its POM manufacturing. The deal enables Celanese to serve existing Tarnoform® customers while leveraging its own assets. Although the transaction includes intellectual property and contracts, it does not encompass employees or manufacturing facilities from Azoty. Senior Vice President Tom Kelly highlighted the acquisition as a strategic move to enhance the growth of Celanese's Engineered Materials business. The closing is anticipated for early July 2021.

Celanese Corporation (NYSE: CE) reported first-quarter 2021 GAAP diluted earnings per share of $2.83, adjusted EPS of $3.46, and net sales of $1.8 billion, reflecting a 15% increase in pricing despite a 3% volume decline. Operating profit stood at $326 million, with adjusted EBIT at $482 million, both surpassing pre-COVID levels. The company faced challenges from Winter Storm Uri, incurring costs but maintaining momentum with a strong outlook of adjusted earnings of approximately $4.00 per share for Q2 2021. Celanese returned $328 million to shareholders through buybacks and dividends.